市場調查報告書

催產素醫藥品的全球市場 - 各適應症、各給藥途徑、各原料、各終端用戶、各地區:市場規模、佔有率、未來展望、機會分析 (2019∼2027年)

Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 924579
出版日期 內容資訊 英文 160 Pages
商品交期: 2-3個工作天內
價格
催產素醫藥品的全球市場 - 各適應症、各給藥途徑、各原料、各終端用戶、各地區:市場規模、佔有率、未來展望、機會分析 (2019∼2027年) Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2020年01月21日內容資訊: 英文 160 Pages
簡介

本報告提供全球催產素醫藥品的市場相關分析,產品概要,及市場基本結構及促進、阻礙因素,整體市場規模預測 (以金額為準,過去2年、今後9年份),各適用症、各用途途徑、各原料、各終端用戶、各地區的詳細趨勢,主要企業的簡介、業績、策略計劃等調查。

第1章 分析目的、前提條件

第2章 市場概要

  • 分析概要
    • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 影響度分析
  • 近來的市場主要動向
  • 產品的銷售
  • 法規方案
  • PEST分析
  • 企業合併、收購 (M&A)

第4章 全球催產素醫藥品市場:各症狀

  • 簡介
  • 不全流產/人工流產
  • 不可避免流產
  • 分娩後出血
  • 分娩誘發
  • 分娩停止

第5章 全球催產素醫藥品市場:各給藥途徑

  • 簡介
  • 肌肉內 (IM) 注射
  • 靜脈內 (IV) 注射

第6章 全球催產素醫藥品市場:各原料

  • 簡介
  • 合成催產素
  • 天然催產素(動物性下垂體萃取物)

第7章 全球催產素醫藥品市場:各終端用戶

  • 簡介
  • 醫院
  • 助產院

第8章 全球催產素醫藥品市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭環境

  • 企業簡介
    • Fresenius Kabi AG
    • Biofutura SpA
    • Baxter Healthcare Corporation
    • Pfizer Inc.
    • Ferring B.V.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.

第10章 附錄

目錄

Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Oxytocic Pharmaceuticals market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Oxytocic Pharmaceuticals market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer Inc., Ferring B.V., Novartis AG, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Oxytocic Pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Oxytocic Pharmaceuticals market

Detailed Segmentation:

  • Global Oxytocic Pharmaceuticals Market, By Indication:
    • Abortion Induced Incomplete
    • Inevitable Abortion
    • Postpartum Hemorrhage
    • Labor Induction
    • Labor Arrest
  • Global Oxytocic Pharmaceuticals Market, By Route of Administration:
    • Intramuscular
    • Intravenous Injection/Infusion
  • Global Oxytocic Pharmaceuticals Market, By Source of Origin:
    • Synthetic Oxytocin
    • Natural Oxytocin (Animal Pituitary Extract)
  • Global Oxytocic Pharmaceuticals Market, By End User:
    • Hospitals
    • Maternity Clinics
  • Global Oxytocic Pharmaceuticals Market, By Region:
    • North America
      • By Indication:
      • Abortion Induced Incomplete
      • Inevitable Abortion
      • Postpartum Hemorrhage
      • Labor Induction
      • Labor Arrest
      • By Route of Administration
      • Intramuscular
      • Intravenous Injection/Infusion
      • By Source of Origin
      • Synthetic Oxytocin
      • Natural Oxytocin (Animal Pituitary Extract)
      • By End User
      • Hospitals
      • Maternity Clinics
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Indication:
      • Abortion Induced Incomplete
      • Inevitable Abortion
      • Postpartum Hemorrhage
      • Labor Induction
      • Labor Arrest
      • By Route of Administration
      • Intramuscular
      • Intravenous Injection/Infusion
      • By Source of Origin
      • Synthetic Oxytocin
      • Natural Oxytocin (Animal Pituitary Extract)
      • By End User
      • Hospitals
      • Maternity Clinics
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Indication:
      • Abortion Induced Incomplete
      • Inevitable Abortion
      • Postpartum Hemorrhage
      • Labor Induction
      • Labor Arrest
      • By Route of Administration
      • Intramuscular
      • Intravenous Injection/Infusion
      • By Source of Origin
      • Synthetic Oxytocin
      • Natural Oxytocin (Animal Pituitary Extract)
      • By End User
      • Hospitals
      • Maternity Clinics
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Indication:
      • Abortion Induced Incomplete
      • Inevitable Abortion
      • Postpartum Hemorrhage
      • Labor Induction
      • Labor Arrest
      • By Route of Administration
      • Intramuscular
      • Intravenous Injection/Infusion
      • By Source of Origin
      • Synthetic Oxytocin
      • Natural Oxytocin (Animal Pituitary Extract)
      • By End User
      • Hospitals
      • Maternity Clinics
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Indication:
      • Abortion Induced Incomplete
      • Inevitable Abortion
      • Postpartum Hemorrhage
      • Labor Induction
      • Labor Arrest
      • By Route of Administration
      • Intramuscular
      • Intravenous Injection/Infusion
      • By Source of Origin
      • Synthetic Oxytocin
      • Natural Oxytocin (Animal Pituitary Extract)
      • By End User
      • Hospitals
      • Maternity Clinics
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Indication:
      • Abortion Induced Incomplete
      • Inevitable Abortion
      • Postpartum Hemorrhage
      • Labor Induction
      • Labor Arrest
      • By Route of Administration
      • Intramuscular
      • Intravenous Injection/Infusion
      • By Source of Origin
      • Synthetic Oxytocin
      • Natural Oxytocin (Animal Pituitary Extract)
      • By End User
      • Hospitals
      • Maternity Clinics
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Fresenius Kabi AG *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Biofutura SpA
    • Baxter Healthcare Corporation
    • Pfizer Inc.
    • Ferring B.V.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Indication
    • Market Snippet, By Route of Administration
    • Market Snippet, By Source of Origin
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • Regulatory Scenario
  • PEST Analysis
  • Mergers and Acquisitions

4. Global Oxytocic Pharmaceuticals Market, By Indication, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Abortion Induced Incomplete
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Inevitable Abortion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Postpartum Hemorrhage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Labor Induction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Labor Arrest
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Intravenous Injection/Infusion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Synthetic Oxytocin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Natural Oxytocin (Animal Pituitary Extract)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Oxytocic Pharmaceuticals Market, By End User, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Maternity Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Oxytocic Pharmaceuticals Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source of Origin, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source of Origin, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source of Origin, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source of Origin, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source of Origin, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source of Origin, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Fresenius Kabi AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biofutura SpA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Baxter Healthcare Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Ferring B.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact